Alzheimer
1 The capacity of albumin to bind to beta-amyloid
2 Human Albumin Grifols 5% in plasmapheresis: a new therapy involving beta-amyloid mobilisation in Alzheimer's disease
3 [Therapeutic plasmapheresis and experience in Alzheimer's disease].
4 Neuroimaging in Alzheimer's disease: findings in plasmapheresis with albumin
5 The Cu(II)/Abeta/human serum albumin model of control mechanism for copper-related amyloid neurotoxicity.
6 Blood-based biomarkers of Alzheimer's disease: challenging but feasible.
7 Amyloid-targeted therapeutics in Alzheimer's disease: use of human albumin in plasma exchange as a novel approach for Abeta mobilization.